Several studies in macrophage cell lines, rodent macrophages, and animal models of atherosclerosis suggest that vitamin E may prevent the formation of foam cells. We tested this hypothesis in a recently developed, fully autologous in vitro model of human foam cell formation. During maturation, macrophages continuously increased their ␣-tocopherol/total cholesterol ratio, demonstrating that these cells accumulate ␣-tocopherol at an even higher rate than cholesterol. In the presence of unsupplemented serum, we observed no correlation between serum vitamin E levels and the increase in the cellular ␣-tocopherol/total cholesterol ratio. In contrast, under supplemented conditions, a 3.1-fold increase in the mean serum ␣-tocopherol/total cholesterol ratio resulted in a corresponding mean 3.5-fold increase in the cellular ␣-tocopherol/total cholesterol ratio. Vitamin E loading had no effect on the lipid composition of macrophages and did not affect their growth. Foam cell formation was stimulated in mature unsupplemented and vitamin E-loaded macrophages for 1 week with 50 g autologous aggregated low density lipoprotein (LDL) in the presence of unsupplemented and vitamin E-loaded serum, respectively. We observed no effect of vitamin E supplementation on the formation of foam cells. However, foam cell formation resulted in a 36% and 44% reduction in the cellular ␣-tocopherol/total cholesterol ratio in unsupplemented and vitamin E-supplemented foam cells, respectively. The loss of vitamin E was accelerated with increasing concentrations of aggregated LDL and was accompanied by an increase in the susceptibility of these foam cells to succumb to the cell lytic effects of oxidized LDL (OxLDL). However, vitamin E supplementation did not protect macrophages or foam cells from OxLDL-mediated cell lysis, suggesting that vitamin E loss in foam cells is not the cause of their increased susceptibility to cell lysis. Our results suggest that the beneficial effects of vitamin E on cardiovascular disease observed in humans are due neither to a reduction in the propensity of macrophages to form foam cells nor to an increased resistance of these cells to cytolytic OxLDL. (Arterioscler Thromb
D ata from a large number of studies strongly suggest that a suboptimal status of any major dietary antioxidant, including vitamin E, increases the risk of cardiovascular disease (for review, see Reference 1) . In particular, the Nurses' Health Study 2 and the Health Professionals Follow-Up Study 3 support the concept that the use of vitamin E supplements is associated with a decreased risk of coronary heart disease. Probably the most intriguing link between plasma antioxidants and atherogenesis is the oxidative modification of LDL as put forward in the "LDL oxidation hypothesis" 4, 5 and the "antioxidant hypothesis of atherosclerosis." 6 -8 LDL oxidation appears to play an important role in atherosclerosis. 9 In vitro, oxidized LDL (OxLDL) possesses a wide array of potentially atherosclerotic properties. 10 It is implicated in the recruitment of monocytes into the subendothelial space 11 and in the inhibition of tissue macrophage motility. 12 In particular, the cytotoxic effects of OxLDL on endothelial and smooth muscle cells 13 as well as on macrophages 14 are likely to contribute to the progression of atherosclerotic lesions. In humans, massive vitamin E supplementation improves the oxidation resistance of isolated LDL, 15 which might explain the antiatherosclerotic properties of vitamin E. However, vitamin E determines only Ϸ20% of the oxidation resistance of LDL. 16, 17 Furthermore, evidence suggests that OxLDL may not exist in plasma and that only oxidation of LDL in the subendothelial space is of importance in the initiation and progression of atherosclerotic lesions. 10 Hence, the beneficial effects of vitamin E could extend beyond the prevention of LDL oxidation. Data obtained from experiments in macrophage cell lines 18 -20 and mouse peritoneal macrophages 21 as well as from ex vivo 22 and in vivo studies in rodents [23] [24] [25] [26] [27] suggest that vitamin E prevents foam cell formation, the hallmark of the earliest detectable atherosclerotic lesions. We tested this hypothesis in human monocyte-derived macrophages by use of a recently developed fully autologous assay to quantify foam cell formation in individuals. 28 
Methods

Isolation and Culture of Human Monocyte-Derived Macrophages
Blood samples (125 mL) were drawn by vein puncture from 8 fasted apparently healthy normolipidemic male volunteers between January 1996 and February 1998. Blood samples were collected in 5 sterile 25-mL blood sampling tubes (Monovette, Sartedt). Three tubes that contained 1.25 mL endotoxin-free 7% citrate solution, pH 7, as an anticoagulant were centrifuged for 30 minutes at 1000g at room temperature, and the plasma was collected for the isolation of autologous LDL. The remaining cell fractions were washed with PBS to remove platelets. Human mononuclear cells were isolated by density gradient centrifugation on low endotoxin Ficoll-separating solution, washed, and cultured in polytetrafluoroethylene (Teflon) bags for 2 weeks as described elsewhere. 29 Autologous serum was obtained from the remaining 50 mL of blood. Mature macrophages were plated at a density of 0.15ϫ10 6 cells per well in 6-well plates. The cell culture medium, referred to from here on simply as culture medium, consisted of RPMI (Biochrom) supplemented with N-acetyl-L-alanyl-L-glutamine (2 mmol/L, Biochrom), nonessential amino acids (1% [vol/vol], Biochrom), penicillin G/streptomycin (100 U/L and 100 g/mL, respectively, Biochrom), and HEPES (10 mmol/L, Fluka Chemie AG). All solutions were routinely tested for endotoxin (LAL-Pyrogen test, Skan AG). Endotoxin levels of the culture medium and all buffers were Ͻ0.03 endotoxin units per milliliter. Cells were plated in culture medium supplemented with 2% autologous human serum. After 2 hours, nonadherent cells were removed through washing with culture medium. Macrophages were incubated in culture medium containing 5% human serum for 48 hours before the experiments. Macrophage yields and their rates of adherence were essentially quantitative, as shown previously. 29 
Lipoproteins
Autologous human LDL was isolated by discontinuous gradient density and flotation ultracentrifugation in a TL-100 ultracentrifuge (Beckman Instruments) equipped with a TLA-100.4 fixed-angle rotor, as described previously. 19 LDL was concentrated by ultrafiltration in Centricon-100 concentrators (Amicon) and was further purified by gel filtration chromatography on Excellulose GF-5 columns (Pierce). To prepare aggregated lipoproteins, 2 mg of freshly isolated LDL was diluted in 1 mL of PBS and vortexed for 60 seconds, as described by Khoo et al. 30 Protein concentrations of all LDL solutions were determined by using bicinchoninic acid (Pierce) with bovine albumin used as a standard.
␣-Tocopherol Supplementation of Autologous Human Serum
A 50-mL Teflon round bottom flask was coated with RRR-␣-tocopherol (Henkel Corp) by evaporating 15 mL hexane containing 10 mg RRR-␣-tocopherol at 37°C under vacuum, as described previously. 31 Autologous serum (15 mL, 50% in culture medium) was added, purged with nitrogen, and rotated in a water bath for 4 hours at 37°C. The loaded serum was sterile-filtered (cellulose acetate, 0.2 m, Costar) and stored at 4°C. ␣-Tocopherol loading affects neither protein nor cholesterol concentrations of the serum. 31
Lipid Extraction
For lipid extraction, the cell supernatants were replaced with PBS for 10 minutes at 37°C. After the incubation period, the supernatants were aspired. Cells were harvested with a rubber policeman. The cell suspensions were divided into aliquots for lipid extraction and DNA measurements. Total lipids of cells or serum were extracted according to a modified technique 32 originally described by Bligh and Dyer. 33 ␦-Tocopherol (Merck) was added before the extraction as an internal standard for ␣-tocopherol measurements (see below). In brief, the volume of the sample was adjusted with water to 800 L, and 3 mL methanol/dichloromethane was added with 0.001% BHT (Merck). The sample was vortexed. Phase separation was obtained by adding 1 mL dichloromethane and 0.5 mL water. The aqueous phase was reextracted twice with 1 mL dichloromethane. The combined organic phase was evaporated under nitrogen at 40°C and stored at Ϫ20°C.
Thin-Layer Chromatography
Thin-layer chromatography was performed as described elsewhere. 32 In brief, lipid samples were resuspended in methanol/dichloromethane (2:1 [vol/vol]). Aliquots were spotted on washed thin-layer chromatographic plates (SIL G-25, layer thickness 0.25 mm, Macherey-Nagel AG; band width 5 mm, distance between bands 6 mm) with a CAMAG Linomat IV (Muttenz). The first separation was performed in heptane/diethyl ether/acetic acid (70:20:4 [vol/vol/ vol]). Plates were then dried at room temperature. To separate triglycerides and cholesteryl esters, the plates were redeveloped in heptane and dried at room temperature. Spots were visualized by molybdatophosphoric acid staining and heating of thin-layer chromatographic plates at 120°C for 4 minutes. 32 The optical density of the plates was analyzed with a Personal Laser Densitometer (Molecular Dynamics). Spot integration was performed with ImageQuant (Molecular Dynamics). Standard curves were fitted with the Marquardt-Levenberg algorithm-based curve fit program supplied with the SigmaPlot graphics program (Jandel Scientific), as described previously. 32 Cholesterol, cholesteryl oleate, and trioleate were used as lipid mass standards. The molecular weight of cholesteryl oleate (651) was used to calculate total cholesterol levels in macrophages as nanomoles per microgram DNA.
␣-Tocopherol Measurements
␣-Tocopherol determinations were performed after lipid extraction of cells or serum (see above). Lipid extracts were separated by reverse-phase high-performance liquid chromatography with a 5-mm C-18 Brownlee column (220ϫ4.6 mm, Applied Biosystems) and methanol used as an eluant (1.5 mL/min). ␣-Tocopherol was detected fluorometrically with a Jasco Spectrofluorometer (model 821-FP, Japan Spectroscopic Co) set at an excitation wavelength of 295 nm and an emission wavelength of 325 nm.
Measurement of Cellular DNA
To determine the cell number in each well, the amount of DNA was determined fluorometrically with use of the fluorescent dye 4Ј,6diamidino-2-phenylindole as described by Brunk et al. 34 Fluorescence was measured in a fluorescence spectrophotometer (model 204-A, Perkin-Elmer) set to an excitation wavelength of 360 nm and an emission wavelength of 450 nm, with both slits set to 10 nm. Cellular DNA content is 9.1 g DNA per 10 6 cells, as determined previously. 29
Assays for Serum Lipids
Serum triglyceride and cholesterol levels were measured with commercial kits (Unimate 5, Hoffmann LaRoche AG).
Membrane Integrity Assay
Membrane integrity was assessed by the [ 3 H]adenine release method described by Reid and Mitchinson. 35 Briefly, macrophages were loaded with [8-3 H]adenine (1 Ci/mL, Amersham) in culture medium with 5% human autologous serum for 2 hours and washed twice with PBS for 10 minutes at 37°C. Cells were then incubated for 48 hours with culture medium, either alone or supplemented with Cu 2ϩ -oxidized LDL; the radioactivity released into the supernatant was measured. LDL oxidation and purification were performed, as described previously. 36 Intracellular radioactivity was measured after cell lysis with 1% (by volume) Triton X-100. Radioactivity was determined by scintillation counting. massive increase in cellular free cholesterol and triglycerides while cholesteryl ester levels decrease. 28 In adherent cultures, 2-week-old mature macrophages continue to grow in size and in the process accumulate more cholesterol and triglycerides. 28 In the present study, we show that vitamin E is also accumulated during this process. For these experiments, 2-week-old mature macrophages from 8 male volunteers, aged 32 to 53 years, were incubated with autologous serum for 1 week (day 0 to day 7), and their ␣-tocopherol/total cholesterol ratios were measured. The ␣-tocopherol/total cholesterol ratios had increased in all 8 macrophage cultures (Table) . The mean increase was 2.2Ϯ0.4-fold, demonstrating that vitamin E is accumulated by macrophages at an even higher rate than is cholesterol. Interestingly, we observed no correlation between the serum levels of vitamin E of the donors and the vitamin E levels of the respective macrophages (Table, day 0). Also, individual vitamin E serum levels were no indicator of the rate of ␣-tocopherol accumulation of a given macrophage culture.
Vitamin E Supplementation of Serum Results in Increased Vitamin E Levels in Macrophages
To study the effect of ␣-tocopherol loading of human serum on macrophage vitamin E levels, blood samples from 8 donors were split into 2 aliquots. Half of the serum obtained from each donor was supplemented with vitamin E. Serum ␣-tocopherol levels and ␣-tocopherol/total cholesterol ratios increased 3.2-fold (from 37.7Ϯ6.6 to 120.1Ϯ30.5 mol/L) and 3.1-fold (from 7.8Ϯ1.1 to 24.4Ϯ4.0 mol/mmol), respectively. Half of each mononuclear fraction was cultured for 2 weeks in Teflon bags in the presence of unsupplemented serum; the other half was cultured in the presence of vitamin E-supplemented serum. Subsequently, mature macrophages were plated and washed. Within 48 hours of being plated, the macrophages adhered firmly to the culture dishes, and their adherence rate was essentially quantitative. 29 Vitamin E levels were measured at this point of culture (day 0, Figure 1 ) and also after 1 week (day 7, Figure 1 ). On both days, supplemented macrophages had a 3.5-fold higher level of vitamin E than did unsupplemented cells, which corresponds with the mean increase in serum vitamin E after supplementation.
Increasing Cellular Vitamin E Does Not Affect Neutral Lipid Levels in Human Macrophages
To assess the effect of vitamin E supplementation on the cellular neutral lipid composition, we extracted macrophages from 8 donors on day 0 and day 7 and analyzed their neutral lipid content. Vitamin E loading affected neither mean cellular cholesterol ( Figure 2A ) nor mean cholesteryl ester ( Figure 2B ) levels. Mean triglyceride levels in ␣-tocopherolloaded macrophages were increased by 18% and 15% on day 0 and day 7, respectively, but these increases were not statistically significant ( Figure 2C ; by Student t test, Pϭ0. 25 and Pϭ0.31, respectively).
Increasing Cellular Vitamin E Does Not Affect Foam Cell Formation
We evaluated the effect of vitamin E loading of human macrophages on their ability to transform into foam cells. Unsupplemented and vitamin E-loaded macrophages from 8 individuals were incubated with 50 g aggregated autologous LDL to stimulate cholesteryl ester accumulation. Foam cell formation was measured as the aggregated LDL-induced increase in cholesteryl esters compared with macrophages incubated in the absence of aggregated LDL. Changes in cholesteryl ester levels due to cell growth were measured separately in each experiment, and values for foam cell formation were corrected accordingly. Vitamin E supplemen- tation had no effect on foam cell formation ( Figure 3 ). Treatment of unsupplemented and ␣-tocopherol-loaded macrophages with 50 g autologous aggregated LDL resulted in a mean increase in cholesteryl ester levels of 1.97 and 2.00 g/g DNA, respectively.
Foam Cell Formation Dramatically Decreases Cellular Vitamin E Levels
The transformation of human macrophages into foam cells induced by 50 g aggregated LDL is characterized by a sharp increase in cholesteryl esters, whereas cholesterol and triglyceride levels essentially remain unchanged. 28 In the present study, we show that lipid-standardized ␣-tocopherol levels decrease dramatically during foam cell formation ( Figure 4 ). We observed an average reduction of the ␣-tocopherol/total cholesterol ratio in unsupplemented and supplemented foam cells of 36Ϯ15% and 44Ϯ12%, respectively. This corresponds to a reduction of the ␣-tocopherol/total cholesterol ratio from 40.7 to 26.0 mol/mmol and from 142.9 to 77.4 mol/mmol in unsupplemented and supplemented macrophages, respectively. However, the cellular concentration of vitamin E (expressed as picomoles ␣-tocopherol per microgram DNA) essentially remained unchanged in unsupplemented cells (ϩ1Ϯ9%) and declined only marginally in vitamin E-supplemented foam cells (Ϫ18Ϯ13%).
Foam Cell Formation Increases Susceptibility to OxLDL-Induced Cell Lysis
As an integral part of the cellular antioxidant defense, vitamin E protects cell membranes from oxidative damage. 37 To test whether the observed reduction in cellular vitamin E results in an increased susceptibility to oxidative damage, we incubated human macrophages with 100 and 200 g aggregated LDL to induce massive foam cell formation. For both concentrations of aggregated LDL, we observed a 30-fold increase in cholesteryl esters, suggesting that these cells reached a maximum in their capacity to accumulate cholesteryl esters. As a result, the vitamin E/total cholesterol ratio decreased from 32.7 to 9.0 and 7.7 mol/mmol for the respective concentrations. Interestingly, under these conditions of massive foam cell formation, we also observed a net loss of cellular vitamin E from 179 to 93 and 74 pmol/mg DNA, respectively. However, this loss of vitamin E only marginally affected the rate of survival of foam cells cultured under serum-free conditions ( Figure 5, control) . In contrast, foam cells exposed for 48 hours to 100 g OxLDL in the absence of serum showed a marked increase in the loss of membrane integrity compared with control macrophages. In the presence of serum, no cytotoxicity of OxLDL was observed in macrophages or foam cells (not shown). Foam cells with a vitamin E level of 9.0 mol/mmol total cholesterol were as resistant to 50 g OxLDL as were control macrophages. However, foam cells with a vitamin E level of 7.7 mol/mmol showed a marked increase in membrane damage. In the presence of 100 g OxLDL, cell death increased to 42% in macrophages and 56% and 86% in foam cells with a vitamin E/total cholesterol ratio of 9.0 and 7.7 mol/mmol, respectively.
Loss of Cellular Vitamin E Does Not Correlate With Increased Cell Lysis by OxLDL
Macrophages from 4 individuals were transformed into foam cells as described above (see Foam Cell Formation Increases Susceptibility to OxLDL-Induced Cell Lysis) and exposed to 100 g OxLDL to induce cell lysis. For all 4 individuals, we obtained results similar to the ones shown in Figure 5 .
Cellular vitamin E levels of foam cells decreased with increasing levels of aggregated LDL. Concurrently, increas-ing the amount of aggregated LDL to induce foam cell formation resulted in an increased susceptibility to cell lysis. However, when cell lysis was plotted against either cellular vitamin E levels (expressed as picomoles ␣-tocopherol per microgram DNA, Figure 6 ) or against the cellular ␣-tocopherol/total cholesterol ratio (not shown), we observed no statistically significant correlation between the parameters F, , f, and ࡗ) . The experiments were conducted as described in the legend to Figure 5 . Values for OxLDLinduced cell lysis (100 g OxLDL per milliliter) were corrected for background, ie, radiolabel release in unstimulated control macrophages. Cell lysis was plotted against cellular vitamin E values, given as pmol/g DNA (9.1 g DNA per 10 6 cells).
(rϭ0.47 and rϭ0.46, respectively). These results suggest that the loss of vitamin E observed during the transformation of macrophages into foam cells is not the cause of their increased susceptibility to OxLDL-induced cell lysis.
Increasing Cellular Vitamin E Does Not Protect Macrophages and Foam Cells From Cell Lysis by OxLDL
To verify that cellular vitamin E does not protect cells from the cell lytic properties of OxLDL, macrophages were loaded with vitamin E. Unsupplemented and vitamin E-supplemented macrophages as well as unsupplemented and vitamin E-supplemented foam cells were exposed to cytolytic OxLDL for 48 hours (Figure 7) . Even though cellular vitamin E levels were increased 4.8-fold and 3.2-fold in macrophages and foam cells, respectively, we observed no significant protection by vitamin E supplementation from OxLDLinduced cell lysis in either cell type. Vitamin E-supplemented macrophages were actually more susceptible to cell lysis than were unsupplemented cells, although the increase was only marginal.
Discussion
We have shown in a previous study that the propensity of human macrophages to transform into foam cells varies Ͼ7-fold among male volunteers, whereas foam cell formation in an individual varies Ͻ25% over a 10-month period. 28 Earlier results from vitamin E supplementation studies in rodents, [22] [23] [24] [25] [26] [27] rodent macrophages, 21 and macrophage cell lines 18 -20 have suggested that variations in the vitamin E levels of human macrophages may account for the large variations in foam cell formation that we had observed between different individuals. Therefore, we in-vestigated whether human foam cell formation is attenuated by vitamin E. To prevent artifacts and minimize the variability of our results, we obtained loaded and untreated macrophages from the same blood sample of a given donor to eliminate any intraindividual differences. The serum concentrations of ␣-tocopherol that we have reported were higher than those reported in other studies for healthy donors from Austrian, 38 Scottish, 39 or Finnish cohorts 40 but were within the range determined for other Swiss cohorts. 38, 41, 42 Finally, to prevent artifacts due to solvents such as ethanol or dimethyl sulfoxide, we used a technique to supplement serum that does not require organic solvents and, instead of forming mainly liposomes, incorporates vitamin E into lipoproteins. 31 In good agreement with results from an earlier study by Garner et al, 43 we have shown in our previous study that human monocytes cultured in autologous serum from fasted subjects increase their neutral lipid mass dramatically during their differentiation into mature macrophages. 28 In the present study, we demonstrate that this also holds true for vitamin E. Not only do mature macrophages continue to accumulate vitamin E, but they accumulate vitamin E at a higher rate than cholesterol, as evidenced by the increase in the ␣-tocopherol/total cholesterol ratios. We measured ␣-tocopherol/total cholesterol ratios of 1 to 2 mol/mmol in 1-day-old monocytes (R.A, unpublished data, 2000). After 2 weeks of nonadherent culture, this ratio increased to 10.1 to 26.4 mol/mmol (day 0, Table) . During the course of the experiments, eg, from day 0 to day 7, the ␣-tocopherol/total cholesterol ratio increased further for all donors (on average, 2.2-fold). The triglyceride content of human monocytes increases 270-fold during the same 3-week maturation period. 28 Therefore, it is likely that the maturing monocytederived macrophage increases its ␣-tocopherol content in an attempt to protect the large numbers of newly acquired fatty acids from oxidation.
Interestingly, the serum ␣-tocopherol level in the present study was no predictor of the degree of vitamin E accumulation in macrophages from a given donor (Table) . Even though the transfer of ␣-tocopherol from lipoproteins to macrophages appears to occur mainly by diffusion, 31 not all lipoproteins may contribute equally. Ziouzenkova et al 38 reported in a study of 59 healthy human subjects that no correlation was found between the ␣-tocopherol content of plasma and LDL. Hence, the distribution of lipoprotein species, their vitamin E levels, and their respective numbers in serum are likely to determine the rate of vitamin E transport into macrophages. By increasing the overall vitamin E content of a given serum in vitro, ie, loading by diffusion, we increased the ability of all lipoproteins that act as vitamin E donors to transfer ␣-tocopherol to macrophages. The degree of vitamin E supplementation most likely depends on the total lipid content of the lipoproteins, not their initial vitamin E level. This would explain why a 3.1-fold increase in the serum ␣-tocopherol/cholesterol ratio resulted in a 3.5-fold increase in the cellular ␣-tocopherol/cholesterol ratio despite the apparent lack of correlation between serum and cellular vitamin E levels under unsupplemented conditions. We had shown in our previous study that no "oxidative burden," eg, LDL oxidation, is required to induce foam cell formation. 28 In fact, OxLDL must be aggregated to induce cholesteryl ester accumulation in human macrophages. According to the "response-to-retention" hypothesis, 44, 45 aggregated and fused LDL particles are likely to be the first modifications of LDL that occur in the vessel wall. Therefore, in the present study, we used in vitro aggregated LDL as a model of early atherogenic LDL to induce foam cell formation. However, we observed no effect of vitamin E supplementation on cholesteryl ester accumulation or any other lipid parameter we measured in our fully autologous human foam cell model. This suggests that in humans, the effect of vitamin E supplementation on early lesion formation is not due to an altered propensity of macrophages to transform into foam cells. However, increased vascular vitamin E levels may reduce the formation of foam cell-inducing aggregates, which in turn would result in fewer foam cells. In apoEdeficient mice, vitamin E supplementation not only reduces LDL oxidation but also its state of aggregation. 26 The reduction in both parameters was accompanied by a decrease in the aortic lesion area. At least in this mouse model of atherogenesis, vitamin E supplementation appears to reduce foam cell formation indirectly by preventing the oxidative modification and subsequent aggregation of LDL.
Contrary to our results in human macrophages, several reports on experiments in cell lines suggest that vitamin E supplementation directly reduces foam cell formation. Particularly, the evidence from experiments in cell lines 18 -20 should be treated with caution. Macrophage cell lines, in contrast to human macrophages, are characterized by high proliferation rates and very low vitamin E levels, which makes these cell lines poor models of human foam cell formation. 19 Exposure to high levels of vitamin E might significantly affect their "normal" lipid metabolism.
Data from several animal studies appear to support an inhibitory role of vitamin E on foam cell formation and the appearance of fatty streaks. [22] [23] [24] [25] [26] [27] Vitamin E levels in the diet of laboratory animals vary dramatically from country to country. 46 This may explain why at least one study in C57BL/6 mice found no reduction in fatty streak formation after vitamin E supplementation. 47 In some studies, animals were fed ␣-tocopherol doses that were 10-fold to 30-fold higher than those in the animals' regular diet. 25, 27 Hence, extrapolation of data from animal models to the human may not be warranted, at least not with regard to vitamin E supplementation and foam cell formation. In particular, macrophages from animals kept on a low vitamin E diet (30 mg/kg), as in France or the United States, are likely to respond differently to atherogenic stimuli, especially after massive vitamin E supplementation, than are cells from rodents that continuously received a high vitamin E diet (200 mg/kg), as in Germany. 46 In human cardiovascular disease, epidemiological data support a protective role of antioxidants. However, intervention trials have yielded rather mixed results. 48 Our results would predict that vitamin E supplementation in humans would not significantly reduce lesion formation because the development of fatty streaks, the hallmark of early atherosclerotic lesions, would not be prevented. Indeed, in humans, vitamin E supplementation showed a modest effect at best on the development and progression of atherosclerosis. 49 The observed modest benefits of vitamin E may be due to protective effects on the endothelium or the inhibition of smooth muscle cell proliferation 50 rather than a reduction in foam cells.
Although vitamin E has no effect on human foam cell formation, we found a dramatic effect of aggregated LDL on macrophage ␣-tocopherol levels. At low concentrations of aggregated LDL (50 g/mL), only the ␣-tocopherol/total cholesterol ratio was reduced, but the total cellular vitamin E level was not significantly affected. The average ␣-tocopherol/total cholesterol ratio in native LDL isolated from 21 Swiss male volunteers is 3.80Ϯ0.59 mol/mmol (R.A., unpublished data, 2000), which is 2.7-fold to 11.8-fold lower than the cellular ␣-tocopherol/total cholesterol ratio in mature macrophages (see Table) . Therefore, the massive uptake and accumulation of aggregated LDL would contribute far more cholesterol than vitamin E to the cells and thereby reduce the cellular ␣-tocopherol/total cholesterol ratio. In the presence of higher concentrations of aggregated LDL (100 and 200 g/mL), macrophages showed a marked reduction not only in their cellular ␣-tocopherol/total cholesterol ratio but also in their ␣-tocopherol/DNA ratio; ie, they actually lost vitamin E per cell. On the basis of our studies in P388D 1 cells, 31 we believe that concurrently with the uptake of aggregated LDL-derived cholesterol, some cellular cholesterol may already be exported or released by the cells in an attempt to reduce the rapidly increasing cellular cholesterol levels. Because vitamin E tends to migrate along with cholesterol, 31 it is very likely that under these conditions of massive foam cell formation, significant amounts of cellular vitamin E leave the macrophages along with cholesterol.
Surprisingly, the net loss of vitamin E was not correlated with the increased susceptibility of foam cells to OxLDLinduced cell lysis. Furthermore, supplementation of macrophages and foam cells with vitamin E showed no protection from the cell lytic effect of OxLDL. Therefore, we conclude that the loss of vitamin E during the formation of foam cells is not the cause of their increased susceptibility to cell lysis. Why foam cells become more susceptible to cell lysis is unclear at this time. Because foam cell death may play a crucial role in the destabilization of atherosclerotic plaques, 51 our results would indicate that vitamin E supplementation should not show any substantial benefits with regard to the clinical outcomes of plaque rupture. However, the Cambridge Heart Antioxidant Study (CHAOS), 52 a randomized, placebocontrolled trial, demonstrated a significant reduction of cardiovascular events by vitamin E. Patients in the CHAOS study received high doses (400 to 800 IU/d) of vitamin E. The "LDL oxidation hypothesis" predicts that vitamin E should prevent the oxidative modifications of LDL. 5 However, according to more recent studies, it is unlikely that vitamin E supplementation would have reduced LDL oxidation in lesions from these patients. Whereas the ␣-tocopherol/cholesterol ratio is decreased in lesions, 53 vitamin E levels are elevated in atherosclerotic plaque compared with healthy arterial tissue. 53, 54 Nevertheless, oxidized lipids and cytotoxic OxLDL are abundant in these advanced lesions. 55, 56 If vitamin E supplementation does not prevent or even reduce LDL oxidation in advanced lesions, the observed beneficial effects of high doses of vitamin E must lie elsewhere. A cytoprotective effect of extracellular vitamin E, similar to the one seen with serum in our macrophage lysis assay, may account for some of the benefits. The prevention of necrotic foam cell death most certainly would slow down the process of plaque destabilization, which otherwise would lead to plaque rupture and its clinical manifestations. 51 However, at the high doses of vitamin E administered in the CHAOS study, the antithrombotic properties of vitamin E 7 may have also contributed significantly to the observed reduction in cardiovascular events.
In conclusion, we suggest that the beneficial effects observed after the treatment of patients with vitamin E are not due to a reduced propensity of macrophages to transform into foam cells. Nor does vitamin E supplementation reverse the increased susceptibility of foam cells to OxLDL-induced cell lysis. Instead, the protection by increased extracellular ␣-tocopherol of macrophages and, in particular, foam cells from the cell lytic activity of OxLDL may explain at least some of the beneficial effects of vitamin E.
